The Abstract Submission Deadline of March 4th was extended until March 12th. The Scientific Advisory Board is now reviewing the 308 abstracts submitted with the goal to send out abstract notifications by April 15th. The Early-Bird Registration Deadline is now extended to April 17th.
LATE BREAKING Poster Abstract Submission now open, with a submission deadline of May 13, 2024.
Requests for VISA Invitations
Interested participants who will require visas should contact the Meeting Organizer as soon as possible for an invitation letter.
Trainee Abstract Awards (Application Deadline was April 5, 2024)
On behalf of the EBV Association and KSHV Research Community, we look forward to awarding a number of abstract award registration fee waivers for qualifying trainees (graduate students, postdocs and pre-doctoral study technicians working in academic or government labs). These awards will be dependent on the outcome of applications for funding that are still pending and will be prioritized to current graduate students, followed by other trainees. Abstract award registration waivers will be distributed based on the ranking of the abstracts by the scientific advisory board. All graduate students, postdocs and pre-doctoral study technicians working in academic or government labs submitting an abstract and applying for a Trainee Abstract Award should upload a pdf document from their advisor or institution verifying their status at the time of abstract submission.
Additional Abstract Submission
One abstract submission and presentation (oral or poster depending on the decision of the organizing committee) is complimentary for those who submit by the abstract submission deadline and are accepted. If you would like to submit an additional abstract, and more than one abstract is accepted for oral or poster presentation, an additional $50.00 will be assessed for each additional presentation and an invoice will be sent to the presenting author.
The online Abstract System (Oxford Abstracts) is separate from the online meeting registration system. Please click here for meeting registration: https://ebv.ksvirus.org/registration/
Abstract Submission Categories:
You will be asked to choose the category below that best fits the subject matter of your abstract. You may choose more than one category:
- EBV
- KSHV
- MHV68
- Non-human primate g-herpesviurs
- Other Oncogenic heresviruses
- Other
Abstract Submission Topics:
- Vaccines, Therapeutics, Clinical Care
- Epigenetics, Gene Expression and Reactivation
- Lytic Cycle/Viral Replication/Reactivation
- Latency
- Viral Entry and Egress
- Transformation/oncogenesis
- Virus/Host Interactions
- Epidemiology
- Innate and Adaptive Immunity, viral evasion
- Viral Pathogenesis including multiple sclerosis and autoimmunity
- Autoimmunity including Multiple Sclerosis
- Metabolism
- Non-coding RNAs and exosomes
- Co-Infections/Microbiome and Virome
- Viral structure
Abstract Guidelines
Abstract deadline extended to Tuesday, March 12th at midnight – USA Eastern Daylight Time. Please use the online form above, that is the only way to submit an abstract.
Before beginning your abstract submission, please collect the following:
- Presenting authors and co-authors contact information and affiliation
- Principal Investigator/Lab Head name, email and affiliation
Abstract Submission Guidelines
- Only create one account for abstract submission which will also used for meeting registration
- 300 word count limit
- Select your presentation preference, oral, poster or either oral or poster
- Include all authors and affiliations in submission, including the submitting author, any co-authors, and Principal Investigator/Lab Head, identify one author as the presenting author
- All abstracts must be submitted and presented in English with spelling and grammar of a quality suitable for publication
- All submissions will print the exact way they are submitted
Review Procedures
- All submittals are reviewed by the conference program committee
- Proposals constituting sales pitches for products or services will not be considered
- Any oral submissions not chosen for an oral presentation will receive a poster presentation
- Authors will be notified of the abstract acceptance/rejection on April 8, 2024